Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 USD | +0.14% |
|
-0.83% | +10.00% |
30/04 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
29/04 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.00% | 45Cr | |
+2.08% | 9.52TCr | |
-0.13% | 3.75TCr | |
-10.28% | 3.38TCr | |
+77.76% | 2.82TCr | |
-14.79% | 1.56TCr | |
-2.82% | 1.36TCr | |
-12.76% | 1.15TCr | |
+181.73% | 1.08TCr | |
-53.92% | 923.34Cr |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Craig-Hallum Adjusts Price Target on Avid Bioservices to $35 From $29, Keeps Buy Rating